Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Loading articles...

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.

Prohost BiotechResearch Platform

Home Articles Categories Tags Subscribe

Tag

#Cellceutix Corporation (CTIX)

2 articles found with this tag

Showing 1 to 2 of 2 articles

Today's Highlights

Incyte Drug Baricitinib Has Promising Results in Rheumatoid Arthritis and More News

In December 2009, Lilly (LLY) and Incyte (INCY) announced an exclusive worldwide license and collaboration agreement for the development and commercialization ofbaricitinib and certain follow-on compo...

Prohost Biotech

Dec 11, 2014

Today's Highlights

In Search for Breakthroughs. See Also: CTIX, CUR, NAVB and SGMO

IN SEARCH FOR BREAKTHROUGHS In The N e w s The publishers of pharmaceutical publications In Vivo, Startup, and The Pink Sheet have chosen Brilacidin Phase II ABSSSI as a "Top Project to Watch." The...

Prohost Biotech

Oct 10, 2013

Prohost BiotechResearch Platform

Advancing biotechnology through cutting-edge research, innovation, and scientific collaboration.

Platform

Articles Categories Tags

Resources

About Us FAQ Contact Privacy Policy Terms & Conditions Cookie Policy

© 2026 Prohost Biotech. All rights reserved. Prohost Biotech is a registered trademark of Prohost Biotech.